Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The FDA has granted marketing approval for Teva Pharmaceutical Industries' generic version of Schwarz Pharma's hypertension drug Uniretic.
Subscribe to our email newsletter
Teva said that the agency had approved its abbreviated new drug application for moexipril HCl and hydrochlorothiazide tablets, in 7.5mg/12.5mg, 15mg/12.5 mg and 15mg/25mg strengths. The company said that shipment of these products will begin immediately.
Israel-based Teva said that Uniretic has annual sales of approximately $30 million in the US, based on IMS sales data.